TMCnet News

Research and Markets: China Human Vaccine Industry Report, 2011-2012
[June 12, 2012]

Research and Markets: China Human Vaccine Industry Report, 2011-2012


DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/cnr66p/china_human_vaccin) has announced the addition of the "China Human Vaccine Industry Report, 2011-2012" report to their offering.

After decades of development, China has become one of the major producer and consumers of human vaccine around the world. In 2011, human vaccine manufacturers numbered 38 in China and the lot release quantity of human vaccine footed up to roughly 770 million person-portions, with market size reaching around RMB1 billion. Moreover, being restricted by the barriers such as vaccine industry policy, technology and capital, it is not easy for companies to set foot in this field and the industry has been with high profitability as a whole. From 2007 to 2011, the gross margin of vaccine business of major manufacturers basically maintained above 60%, and some enterprises such as Walvax Biotechnology and Liaoning Chengda even enjoyed the gross margin of as high as 90 or so.



Although Japanese Encephalitis Vaccine, Hepatitis A Vaccine and Influenza Vaccine have been exported to other countries, they are mainly consumed in China. However, China's vaccine supervisory system was approved by the WHO in March 2011, which may eventually open the door for Chinese vaccines to be distributed globally. In 2011, Tiantan Biological signed a cooperation agreement on oral polio vaccine (OPV) with Bill & Melinda Gates Foundation, according to which, the company will annually supply 160 million OPV doses for United Nations International Children's Emergency Fund (UNICEF) at the negotiated price after its Yizhuang-based Vaccine Workshop is built and has its vaccines pre-qualified by the WHO.

The report not only highlights the domestic and international operating environment, overall situation and market supply & demand of Chinese human vaccine industry, and market segments and prospects of 10 vaccines, but also analyzes the competition pattern, as well as operation, advantages and new product R&D dynamics of 11 human vaccine manufacturers.


Key Topics Covered:

1. Overview of Vaccine Industry

2. China Human Vaccine Industry

3. Human Vaccine Market Segments in China

4. Import and Export of Human Vaccine in China

5. Major Human Vaccine Manufacturers in China

Companies Mentioned:

- China National Biotec Group

- Beijing Tiantan Biological Products Co., Ltd

- Hualan Biological Engineering Inc.

- Chongqing Zhifei Biological Products Co., Ltd.

- Walvax Biotechnology Co., Ltd.

- Sinovac Biotech Ltd.

- Liaoning Chengda Co., Ltd.

- Changchun BCHT Biotechnology Co., Ltd.

- Changchun Changsheng Life Sciences Limited

- Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd.

- Shenzhen Kangtai Biological Products Co. Ltd.

- Dalian Hissen Bio-Pharm Co., Ltd.

For more information visit http://www.researchandmarkets.com/research/cnr66p/china_human_vaccin


[ Back To TMCnet.com's Homepage ]